We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+9.96%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$25.2B
AUM Growth
-$335M
(-1.3%)
Cap. Flow
-$2.05B
Cap. Flow
% of AUM
-8.13%
Top 10 Holdings %
Top 10 Hldgs %
26.87%
Holding
1,147
New
127
Increased
298
Reduced
504
Closed
194
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$160M |
| 2 |
Masco
MAS
|
+$134M |
| 3 |
Lam Research
LRCX
|
+$112M |
| 4 |
Coupang
CPNG
|
+$101M |
| 5 |
Nu Holdings
NU
|
+$98.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$205M |
| 2 |
Lennox International
LII
|
+$191M |
| 3 |
NVIDIA
NVDA
|
+$169M |
| 4 |
Tractor Supply
TSCO
|
+$157M |
| 5 |
Apple
AAPL
|
+$151M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.69% |
| 2 | Consumer Discretionary | 12.85% |
| 3 | Industrials | 12.71% |
| 4 | Financials | 12.68% |
| 5 | Healthcare | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1051
Metropolitan Bank Holding Corp
MCB
$1.14B
| – | – |
-6,904
| Closed | -$483K |
|
1052
MiMedx Group
MDXG
$658M
| – | – |
-30,516
| Closed | -$186K |
|
1053
Medpace
MEDP
$16B
| – | – |
-116,249
| Closed | -$36.5M |
|
|
MLNK
1054
DELISTED
MeridianLink
MLNK
| – | – |
-81,556
| Closed | -$1.32M |
|
1055
Altria Group
MO
$125B
| – | – |
-3,747
| Closed | -$220K |
|
|
MRSN
1056
DELISTED
Mersana Therapeutics
MRSN
| – | – |
-53,318
| Closed | -$395K |
|
1057
MaxLinear
MXL
$5.33B
| – | – |
-687,351
| Closed | -$9.77M |
|
1058
NBT Bancorp
NBTB
$2.8B
| – | – |
-46,724
| Closed | -$1.94M |
|
1059
NiSource
NI
$22B
| – | – |
-16,685
| Closed | -$673K |
|
1060
Nicolet Bankshares
NIC
$3.64B
| – | – |
-13,157
| Closed | -$1.62M |
|
1061
Nike
NKE
$63.6B
| – | – |
-6,264
| Closed | -$445K |
|
1062
Newmark Group
NMRK
$2.88B
| – | – |
-63,257
| Closed | -$769K |
|
1063
NN Inc
NNBR
$264M
| – | – |
-17,758
| Closed | -$37.3K |
|
1064
Neuropace
NPCE
$521M
| – | – |
-51,972
| Closed | -$579K |
|
1065
Natera
NTRA
$36.2B
| – | – |
-4,333
| Closed | -$732K |
|
1066
Northwest Natural Holdings
NWN
$2.21B
| – | – |
-46,543
| Closed | -$1.85M |
|
1067
OceanFirst Financial
OCFC
$1.74B
| – | – |
-99,132
| Closed | -$1.75M |
|
|
ODP
1068
DELISTED
ODP
ODP
| – | – |
-185,928
| Closed | -$3.37M |
|
1069
Omega Flex
OFLX
$308M
| – | – |
-24,445
| Closed | -$792K |
|
1070
Olema Pharmaceuticals
OLMA
$1B
| – | – |
-194,450
| Closed | -$828K |
|
1071
Omnicom Group
OMC
$24.5B
| – | – |
-25,100
| Closed | -$1.81M |
|
1072
Ooma
OOMA
$599M
| – | – |
-30,623
| Closed | -$395K |
|
1073
Option Care Health
OPCH
$3.54B
| – | – |
-92,083
| Closed | -$2.99M |
|
1074
Opendoor
OPEN
$3.78B
| – | – |
-7,568,016
| Closed | -$3.9M |
|
1075
Oric Pharmaceuticals
ORIC
$1.24B
| – | – |
-76,447
| Closed | -$776K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2025 Portfolio in Review
As of Q3 2025, Jacobs Levy Equity Management held 1,147 positions worth $25.2B, down 1.3% from $25.5B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jacobs Levy Equity Management withdrew a net $2.05B in Q3 2025, closing 194 positions and reducing 504 holdings. Its most notable exit was Progressive, an estimated $66.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, Jacobs Levy Equity Management opened a new position in Bank of America worth $45M.
- Jacobs Levy Equity Management's largest Q3 2025 buy was Bank of America: 873,228 shares worth $45M.
- Jacobs Levy Equity Management added most to Alnylam Pharmaceuticals in Q3 2025, an estimated $160M increase.
- Jacobs Levy Equity Management's biggest Q3 2025 reduction was GE Vernova, cutting an estimated $205M.
- Jacobs Levy Equity Management fully exited Progressive in Q3 2025, selling an estimated $66.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 27% of its $25.2B portfolio in Q3 2025.
- Jacobs Levy Equity Management opened 127 new positions and closed 194 in Q3 2025.
- Jacobs Levy Equity Management's portfolio value fell 1.3% quarter-over-quarter to $25.2B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2025, filed 17 Nov 2025.